Patents by Inventor Silvia Tampucci

Silvia Tampucci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230082870
    Abstract: The present invention relates to a formulation in the form of an aqueous suspension comprising calcium citrate. Said formulation exhibits excellent stability and compliance and finds use in calcium supplementation in subjects in need of such supplementation.
    Type: Application
    Filed: October 25, 2022
    Publication date: March 16, 2023
    Applicant: ABIOGEN PHARMA S.P.A.
    Inventors: Laura Dini, Fabio Neggiani, Patrizia Chetoni, Silvia Tampucci
  • Publication number: 20220409630
    Abstract: The invention relates to topical ophthalmic preparations in eye drops containing bimatoprost as an active ingredient at the concentration of 0.1 mg/ml, wherein the presence of benzalkonium chloride is limited to the indispensable minimum commonly required for its activity as an antimicrobial preservative, i.e. from 50 at 80 ppm, and the bioavailability of the product is ensured by the addition of specific non-ionic surfactants, i.e., poloxamers.
    Type: Application
    Filed: November 2, 2020
    Publication date: December 29, 2022
    Inventors: Patrizia CHETONI, Susi BURGALASSI, Daniela MONTI, Silvia TAMPUCCI, Giulia FALCONE, Christina MATSIGKOU
  • Publication number: 20220233696
    Abstract: The present invention describes topical formulations for use in photodynamic therapy (PDT) of skin affections, said formulations comprising a Zn-phthalocyanine derivative.
    Type: Application
    Filed: March 6, 2020
    Publication date: July 28, 2022
    Inventors: Giacomo RONCUCCI, Lia FANTETTI, Annalisa COCCHI, Moira MUNICCHI, Francesco GIULIANI, Silvia TAMPUCCI, Daniela MONTI, Giacomo CHITI
  • Publication number: 20200375897
    Abstract: The present invention relates to a formulation in the form of an aqueous suspension comprising calcium citrate. Said formulation exhibits excellent stability and compliance and finds use in calcium supplementation in subjects in need of such supplementation.
    Type: Application
    Filed: September 6, 2018
    Publication date: December 3, 2020
    Applicant: ABIOGEN PHARMA S.P.A.
    Inventors: Laura Dini, Fabio Neggiani, Patrizia Chetoni, Silvia Tampucci